An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA(R)) in adults: safety, tolerability, and immunogenicity

By Linglof T.   van Hattum J.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3968-3971

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

A randomized study of a flexible booster dosing regimen of VAQTA(R) in adults: safety, tolerability, and immunogenicity

By Hornick R.   Tucker R.   Kaplan K.M.   Eves K.A.   Banerjee D.   Jensen E.   Kuter B.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4727-4731

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

By Fisch A.   Cadilhac P.   Vidor E.   Prazuck T.   Dublanchet A.   Lafaix C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1132-1136

Elsevier

Access to resources Recommend Favorite

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

By Garin D.   Vidor E.   Wallon M.   Fanget B.   Brasseur P.   Delolme H.   Caron F.   Mojon M.   Gravey A.   Humbert G.   Flehmig B.   Peyron F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite